Financial Summary (All financials)
| In millions, except per share items | Sep-30-14 | Sep-30-13 | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 |
| Revenues | 0.8 | 2.4 | 2.2 | 7.2 | 4.4 | 7,378.0 | 10,168.0 |
| Revenue growth | -65.2% | 10.1% | -69.9% | 63.3% | -99.9% | -27.4% | |
| Cost of goods sold | 0.6 | 1.5 | 1.3 | 4.0 | 2.2 | 4,005.0 | 5,728.0 |
| Gross profit | 0.3 | 0.9 | 0.8 | 3.2 | 2.2 | 3,373.0 | 4,440.0 |
| Gross margin | 31.8% | 38.8% | 38.0% | 44.5% | 48.9% | 45.7% | 43.7% |
| Selling, general and administrative | 1.6 | 1.7 | 2.1 | 2.4 | 3.0 | 4,535.0 | 4,926.0 |
| Research and development | 0.4 | 0.3 | 0.7 | 0.7 | 0.8 | 623.0 | 963.0 |
| EBIT | -1.7 | -1.1 | -2.0 | 0.0 | -1.6 | -1,785.0 | -1,449.0 |
| EBIT margin | -203.0% | -45.0% | -93.7% | 0.7% | -37.4% | -24.2% | -14.3% |
| Pre-tax income | -2.6 | -1.5 | -2.2 | -0.1 | -1.8 | -1,837.0 | -1,389.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 2.0 |
| Net income | -2.6 | -1.5 | -2.2 | -0.1 | -1.8 | -1,839.0 | -1,391.0 |
| Net margin | -312.9% | -64.7% | -101.2% | -1.3% | -40.5% | -24.9% | -13.7% |
| |
| Diluted EPS | ($0.10) | ($0.06) | ($0.09) | $0.00 | ($0.08) | ($90.12) | ($0.07) |
| Shares outstanding (diluted) | 25.0 | 25.0 | 25.0 | 25.1 | 22.3 | 20.4 | 19,948.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|